Amicus Therapeutics Buyout Advances As Valuation Gap Draws Investor Focus [Yahoo! Finance]
Amicus Therapeutics, Inc. (FOLD)
Last amicus therapeutics, inc. earnings: 11/11 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amicusrx.com/investor-relations
Company Research
Source: Yahoo! Finance
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Shareholders of Amicus Therapeutics have approved the company's acquisition by BioMarin Pharmaceutical. The deal now moves to remaining regulatory reviews before the parties can close the transaction. The acquisition is expected to close following completion of these final approvals, subject to customary conditions. For holders of NasdaqGM:FOLD, this vote marks a clear inflection point for Amicus Therapeutics, which last closed at $14.33. The stock has returned 56.6% over the past year and 37.9% over the past five years. These figures reflect how the market has treated the company over different time frames. This pending combination with BioMarin could reshape how Amicus Therapeutics' rare disease portfolio and pipeline are developed and supported once all approvals are in place. Investors will likely focus on closing progress, any updated deal milestones, and what th
Show less
Read more
Impact Snapshot
Event Time:
FOLD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FOLD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FOLD alerts
High impacting Amicus Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FOLD
News
- Amicus Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate UpdatesGlobeNewswire
- TD Cowen Cautious on Amicus Therapeutics (FOLD) Despite Positive 2025 Revenue Projections [Yahoo! Finance]Yahoo! Finance
- Is Amicus Therapeutics (FOLD) Pricing Reflect Long Term Prospects In Rare Disease Treatments [Yahoo! Finance]Yahoo! Finance
- Assessing Amicus Therapeutics (FOLD) Valuation After Strong 3 Month And 1 Year Shareholder Returns [Yahoo! Finance]Yahoo! Finance
FOLD
Earnings
- 2/20/26 - Beat
FOLD
Sec Filings
- 3/4/26 - Form 4
- 3/3/26 - Form 8-K
- 3/2/26 - Form 144
- FOLD's page on the SEC website